0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Antibody Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-1W2261
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Antibody Market Insights and Forecast to 2028
BUY CHAPTERS

Global Recombinant Antibody Market Research Report 2024

Code: QYRE-Auto-1W2261
Report
January 2024
Pages:72
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Antibody Market Size

The global Recombinant Antibody market was valued at US$ 161 million in 2023 and is anticipated to reach US$ 178.6 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.

Recombinant Antibody Market

Recombinant Antibody Market

Recombinant antibodies are antibodies produced through genetic engineering techniques, often using mammalian cells or other expression systems. They are used in research, diagnostics, and therapeutics.
The market for recombinant antibodies is growing due to their versatility in applications, including cancer therapy, autoimmune disease treatment, and targeted drug delivery. Advances in antibody engineering and production technologies are contributing to this trend.
This report aims to provide a comprehensive presentation of the global market for Recombinant Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Antibody.

Report Scope

The Recombinant Antibody market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Recombinant Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Recombinant Antibody Market Report

Report Metric Details
Report Name Recombinant Antibody Market
Accounted market size in 2023 US$ 161 million
Forecasted market size in 2030 US$ 178.6 million
CAGR 2.5%
Base Year 2023
Forecasted years 2024 - 2030
Segment by Type
  • Chimeric Antibody
  • Humanized Antibody
  • Full Human Antibody
  • Single Chain Antibody
  • Bispecific Antibody
Segment by Application
  • Hospital
  • Scientific Research
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abnova, Medix Biochemica, GE Healthcare, SinoBiological, Bioventix
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Recombinant Antibody companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Recombinant Antibody Market growing?

Ans: The Recombinant Antibody Market witnessing a CAGR of 2.5% during the forecast period 2024-2030.

What is the Recombinant Antibody Market size in 2030?

Ans: The Recombinant Antibody Market size in 2030 will be US$ 178.6 million.

Who are the main players in the Recombinant Antibody Market report?

Ans: The main players in the Recombinant Antibody Market are Abnova, Medix Biochemica, GE Healthcare, SinoBiological, Bioventix

What are the Application segmentation covered in the Recombinant Antibody Market report?

Ans: The Applications covered in the Recombinant Antibody Market report are Hospital, Scientific Research, Others

What are the Type segmentation covered in the Recombinant Antibody Market report?

Ans: The Types covered in the Recombinant Antibody Market report are Chimeric Antibody, Humanized Antibody, Full Human Antibody, Single Chain Antibody, Bispecific Antibody

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Antibody Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chimeric Antibody
1.2.3 Humanized Antibody
1.2.4 Full Human Antibody
1.2.5 Single Chain Antibody
1.2.6 Bispecific Antibody
1.3 Market by Application
1.3.1 Global Recombinant Antibody Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Antibody Market Perspective (2019-2030)
2.2 Recombinant Antibody Growth Trends by Region
2.2.1 Global Recombinant Antibody Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Recombinant Antibody Historic Market Size by Region (2019-2024)
2.2.3 Recombinant Antibody Forecasted Market Size by Region (2025-2030)
2.3 Recombinant Antibody Market Dynamics
2.3.1 Recombinant Antibody Industry Trends
2.3.2 Recombinant Antibody Market Drivers
2.3.3 Recombinant Antibody Market Challenges
2.3.4 Recombinant Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Recombinant Antibody Players by Revenue
3.1.1 Global Top Recombinant Antibody Players by Revenue (2019-2024)
3.1.2 Global Recombinant Antibody Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Recombinant Antibody Revenue
3.4 Global Recombinant Antibody Market Concentration Ratio
3.4.1 Global Recombinant Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Antibody Revenue in 2023
3.5 Recombinant Antibody Key Players Head office and Area Served
3.6 Key Players Recombinant Antibody Product Solution and Service
3.7 Date of Enter into Recombinant Antibody Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Antibody Breakdown Data by Type
4.1 Global Recombinant Antibody Historic Market Size by Type (2019-2024)
4.2 Global Recombinant Antibody Forecasted Market Size by Type (2025-2030)
5 Recombinant Antibody Breakdown Data by Application
5.1 Global Recombinant Antibody Historic Market Size by Application (2019-2024)
5.2 Global Recombinant Antibody Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Recombinant Antibody Market Size (2019-2030)
6.2 North America Recombinant Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Recombinant Antibody Market Size by Country (2019-2024)
6.4 North America Recombinant Antibody Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Recombinant Antibody Market Size (2019-2030)
7.2 Europe Recombinant Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Recombinant Antibody Market Size by Country (2019-2024)
7.4 Europe Recombinant Antibody Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Recombinant Antibody Market Size (2019-2030)
8.2 Asia-Pacific Recombinant Antibody Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Recombinant Antibody Market Size by Region (2019-2024)
8.4 Asia-Pacific Recombinant Antibody Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Recombinant Antibody Market Size (2019-2030)
9.2 Latin America Recombinant Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Recombinant Antibody Market Size by Country (2019-2024)
9.4 Latin America Recombinant Antibody Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Recombinant Antibody Market Size (2019-2030)
10.2 Middle East & Africa Recombinant Antibody Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Recombinant Antibody Market Size by Country (2019-2024)
10.4 Middle East & Africa Recombinant Antibody Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abnova
11.1.1 Abnova Company Detail
11.1.2 Abnova Business Overview
11.1.3 Abnova Recombinant Antibody Introduction
11.1.4 Abnova Revenue in Recombinant Antibody Business (2019-2024)
11.1.5 Abnova Recent Development
11.2 Medix Biochemica
11.2.1 Medix Biochemica Company Detail
11.2.2 Medix Biochemica Business Overview
11.2.3 Medix Biochemica Recombinant Antibody Introduction
11.2.4 Medix Biochemica Revenue in Recombinant Antibody Business (2019-2024)
11.2.5 Medix Biochemica Recent Development
11.3 GE Healthcare
11.3.1 GE Healthcare Company Detail
11.3.2 GE Healthcare Business Overview
11.3.3 GE Healthcare Recombinant Antibody Introduction
11.3.4 GE Healthcare Revenue in Recombinant Antibody Business (2019-2024)
11.3.5 GE Healthcare Recent Development
11.4 SinoBiological
11.4.1 SinoBiological Company Detail
11.4.2 SinoBiological Business Overview
11.4.3 SinoBiological Recombinant Antibody Introduction
11.4.4 SinoBiological Revenue in Recombinant Antibody Business (2019-2024)
11.4.5 SinoBiological Recent Development
11.5 Bioventix
11.5.1 Bioventix Company Detail
11.5.2 Bioventix Business Overview
11.5.3 Bioventix Recombinant Antibody Introduction
11.5.4 Bioventix Revenue in Recombinant Antibody Business (2019-2024)
11.5.5 Bioventix Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Recombinant Antibody Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Chimeric Antibody
    Table 3. Key Players of Humanized Antibody
    Table 4. Key Players of Full Human Antibody
    Table 5. Key Players of Single Chain Antibody
    Table 6. Key Players of Bispecific Antibody
    Table 7. Global Recombinant Antibody Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Recombinant Antibody Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Recombinant Antibody Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Recombinant Antibody Market Share by Region (2019-2024)
    Table 11. Global Recombinant Antibody Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Recombinant Antibody Market Share by Region (2025-2030)
    Table 13. Recombinant Antibody Market Trends
    Table 14. Recombinant Antibody Market Drivers
    Table 15. Recombinant Antibody Market Challenges
    Table 16. Recombinant Antibody Market Restraints
    Table 17. Global Recombinant Antibody Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Recombinant Antibody Market Share by Players (2019-2024)
    Table 19. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody as of 2023)
    Table 20. Ranking of Global Top Recombinant Antibody Companies by Revenue (US$ Million) in 2023
    Table 21. Global 5 Largest Players Market Share by Recombinant Antibody Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Recombinant Antibody Product Solution and Service
    Table 24. Date of Enter into Recombinant Antibody Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Recombinant Antibody Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Recombinant Antibody Revenue Market Share by Type (2019-2024)
    Table 28. Global Recombinant Antibody Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Recombinant Antibody Revenue Market Share by Type (2025-2030)
    Table 30. Global Recombinant Antibody Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Recombinant Antibody Revenue Market Share by Application (2019-2024)
    Table 32. Global Recombinant Antibody Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Recombinant Antibody Revenue Market Share by Application (2025-2030)
    Table 34. North America Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. North America Recombinant Antibody Market Size by Country (2019-2024) & (US$ Million)
    Table 36. North America Recombinant Antibody Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Europe Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Europe Recombinant Antibody Market Size by Country (2019-2024) & (US$ Million)
    Table 39. Europe Recombinant Antibody Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Asia-Pacific Recombinant Antibody Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Asia-Pacific Recombinant Antibody Market Size by Region (2019-2024) & (US$ Million)
    Table 42. Asia-Pacific Recombinant Antibody Market Size by Region (2025-2030) & (US$ Million)
    Table 43. Latin America Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Latin America Recombinant Antibody Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Latin America Recombinant Antibody Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Middle East & Africa Recombinant Antibody Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 47. Middle East & Africa Recombinant Antibody Market Size by Country (2019-2024) & (US$ Million)
    Table 48. Middle East & Africa Recombinant Antibody Market Size by Country (2025-2030) & (US$ Million)
    Table 49. Abnova Company Detail
    Table 50. Abnova Business Overview
    Table 51. Abnova Recombinant Antibody Product
    Table 52. Abnova Revenue in Recombinant Antibody Business (2019-2024) & (US$ Million)
    Table 53. Abnova Recent Development
    Table 54. Medix Biochemica Company Detail
    Table 55. Medix Biochemica Business Overview
    Table 56. Medix Biochemica Recombinant Antibody Product
    Table 57. Medix Biochemica Revenue in Recombinant Antibody Business (2019-2024) & (US$ Million)
    Table 58. Medix Biochemica Recent Development
    Table 59. GE Healthcare Company Detail
    Table 60. GE Healthcare Business Overview
    Table 61. GE Healthcare Recombinant Antibody Product
    Table 62. GE Healthcare Revenue in Recombinant Antibody Business (2019-2024) & (US$ Million)
    Table 63. GE Healthcare Recent Development
    Table 64. SinoBiological Company Detail
    Table 65. SinoBiological Business Overview
    Table 66. SinoBiological Recombinant Antibody Product
    Table 67. SinoBiological Revenue in Recombinant Antibody Business (2019-2024) & (US$ Million)
    Table 68. SinoBiological Recent Development
    Table 69. Bioventix Company Detail
    Table 70. Bioventix Business Overview
    Table 71. Bioventix Recombinant Antibody Product
    Table 72. Bioventix Revenue in Recombinant Antibody Business (2019-2024) & (US$ Million)
    Table 73. Bioventix Recent Development
    Table 74. Research Programs/Design for This Report
    Table 75. Key Data Information from Secondary Sources
    Table 76. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Antibody Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Recombinant Antibody Market Share by Type: 2023 VS 2030
    Figure 3. Chimeric Antibody Features
    Figure 4. Humanized Antibody Features
    Figure 5. Full Human Antibody Features
    Figure 6. Single Chain Antibody Features
    Figure 7. Bispecific Antibody Features
    Figure 8. Global Recombinant Antibody Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 9. Global Recombinant Antibody Market Share by Application: 2023 VS 2030
    Figure 10. Hospital Case Studies
    Figure 11. Scientific Research Case Studies
    Figure 12. Others Case Studies
    Figure 13. Recombinant Antibody Report Years Considered
    Figure 14. Global Recombinant Antibody Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Recombinant Antibody Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Recombinant Antibody Market Share by Region: 2023 VS 2030
    Figure 17. Global Recombinant Antibody Market Share by Players in 2023
    Figure 18. Global Top Recombinant Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Antibody as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Recombinant Antibody Revenue in 2023
    Figure 20. North America Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Recombinant Antibody Market Share by Country (2019-2030)
    Figure 22. United States Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Canada Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. Europe Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Europe Recombinant Antibody Market Share by Country (2019-2030)
    Figure 26. Germany Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. Asia-Pacific Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Asia-Pacific Recombinant Antibody Market Share by Region (2019-2030)
    Figure 34. China Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Japan Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. South Korea Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Southeast Asia Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. India Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Australia Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. Latin America Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Latin America Recombinant Antibody Market Share by Country (2019-2030)
    Figure 42. Mexico Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Brazil Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Middle East & Africa Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East & Africa Recombinant Antibody Market Share by Country (2019-2030)
    Figure 46. Turkey Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Saudi Arabia Recombinant Antibody Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Abnova Revenue Growth Rate in Recombinant Antibody Business (2019-2024)
    Figure 49. Medix Biochemica Revenue Growth Rate in Recombinant Antibody Business (2019-2024)
    Figure 50. GE Healthcare Revenue Growth Rate in Recombinant Antibody Business (2019-2024)
    Figure 51. SinoBiological Revenue Growth Rate in Recombinant Antibody Business (2019-2024)
    Figure 52. Bioventix Revenue Growth Rate in Recombinant Antibody Business (2019-2024)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Anti-Anxiety Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23Q7423
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Real-Time Thermal Cyclers Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-39X13417
Thu Mar 28 00:00:00 UTC 2024

Add to Cart

Global Actarit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-3Q7887
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Bepotastine Besilate Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-14X7647
Fri Feb 23 00:00:00 UTC 2024

Add to Cart